Corticosterone changes in response to stressors, acute and protracted actions of tumor necrosis factor-α, and lipopolysaccharide treatments in mice lacking the tumor necrosis factor-α p55 receptor gene

NeuroImmunoModulation

Volumn 11, Issue 4, 2004, Pages 241-246

  Hayley, Shawn ^a,b   Kelly, Owen ^a   Anisman, Hymie ^a  

^a CARLETON UNIVERSITY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Corticosterone; Knockout; Sensitization; Tumor necrosis factor

Indexed keywords

CORTICOSTEROID; LIPOPOLYSACCHARIDE; PROTEIN P55; RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; FEMALE; GENE DELETION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMOBILIZATION STRESS; MALE; MOUSE; NOISE; NONHUMAN; PRIORITY JOURNAL; STRESS; WILD TYPE;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD; CORTICOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFLAMMATION; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PITUITARY-ADRENAL SYSTEM; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; STRESS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3142723337     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000078442     Document Type: Article

References (31)

1. Anisman H, Hayley S, Merali Z: Behavioral and central neurochemical consequences of cytokine challenge; in Bienenstock J, Gorzynski R, Berczi I (eds): Neuroimmune Biology: New Foundation of Biology. Elsevier Science 2001:141-162.
2. Hayley S, Brebner K, Lacosta S, Merali Z, Anisman H: Sensitization to the effects of tumor necrosis factor-α: Neuroendocrine, central monoamine and behavioral variations. J Neurosci 1999;19:5654-5665.
3. Hayley S, Wall P, Anisman H: Behavioral and neurochemical sensitization effects of tumor necrosis factor-α: Central and peripheral mechanisms. Eur J Neurosci 2002;15:1-17.
4. Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, Lysko PG, Feuerstein GZ: Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 1997;28:1233-1244.
5. Mogi M, Togari A, Kondo T, Mizuno Y, Komure O, Kuno S, Ichinose H, Nagatsu T: Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from parkinsonian brain. J Neural Transm 2000;107:335-341.
6. Bernardini R, Kamilaris TC, Calogero AE, Johnson EO, Gomez MT, Gold PW, Chrousos GP: Interactions between tumor necrosis factor-α, hypothalamic corticotropin-releasing hormone, and adrenocorticotropin secretion in the rat. Endocrinology 1990;126:2876-2881.
7. Hayley S, Staines W, Merali Z, Anisman H: Time-dependent sensitization of corticotropinreleasing hormone, arginine vasopressin and c-fos immunoreactivity within the mouse brain in response to tumor necrosis factor-alpha. Neuroscience 2001;106:137-148.
8. Schmidt ED, Janszen AWJW, Wouterlood FG, Tilders FJH: Interleukin-1 induced long-lasting changes in hypothalamic corticotropin-releasing hormone (CRH) neurons and hyperresponsiveness of the hypothalamic-pituitary-adrenal axis. J Neurosci 1995;15:7417-7426.
9. Hayley S, Kelly O, Anisman H: Murine tumor necrosis factor-α sensitizes plasma corticosterone and manifestation of shock: Modulation by histamine. J Neuroimmunol 2002;131:60-69.
10. Beutler BA: The role of tumor necrosis factor in health and disease. J Rheumatol 1999;57:16-21.
11. Nadeau S, Rivest S: Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: A view from the blood-brain barrier. Neuroscience 1999;93:1449-1464.
12. Akassoglou K, Bauer J, Kassiotis G, Pasparakis M, Lassmann H, Kollias G, Probert L: Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: Models for multiple sclerosis with primary oligodendrogliopathy. Am J Pathol 1998;153:801-813.
13. Gary DS, Bruce-Keller AJ, Kindy MS, Mattson MP: Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor. J Cereb Blood Flow Metab 1995;18:1283-1287.
14. Fang J, Wang Y, Krueger JM: Mice lacking the TNF 55 kDa receptor fail to sleep more after TNFalpha treatment. J Neurosci 1997;17:5949-5455.
15. Benigni F, Faggioni R, Sironi M, Fantuzzi G, Vandenabeele P, Takahashi N, Sacco S, Fiers W, Buurman WA, Ghezzi P: TNF receptor p55 plays a major role in centrally mediated increases of serum IL-6 and corticosterone after intracerebroventricular injection of TNF. J Immunol 1996;157:5563-5568.
16. Ando T, Dunn AJ: Mouse tumor necrosis factor-alpha increases brain tryptophan concentrations and norepinephrine metabolism while activating the HPA axis in mice. Neuroimmunomodulation 1999;6:319-329.
17. Hale KD, Ghanta VK, Gauthier DK, Hiramoto RN: Effects of rotational stress of different duration on NK cell activity, proinflammatory cytokines, and POMC-derived peptides in mice. Neuroimmunomodulation 2001;9:34-40.
18. Shintani F, Nakaki T, Kanba S, Sato K, Yagi G, Shiozawa M, Aiso S, Kato R, Asai M: Involvement of interleukin-1 in immobilization stress-induced increase in plasma adrenocorticotropic hormone and in release of hypothalamic monoamines in the rat. J Neurosci 1998;15:1961-1970.
19. Pfeffer K, Matsuyama T, Kundig TM, Wakeham A, Kishihara K, Shahinian A, Wiegmann K, Ohashi PS, Kronke M, Mak TW: Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 1993;73:457-467.
20. Kurschner VC, Petruzzi RL, Golden GT, Berrettini WH, Ferraro TN: Kainate and AMPA receptor binding in seizure-prone and seizureresistant inbred mouse strains. Brain Res 1998;780:1-8.
21. Uzonna JE, Kaushik RS, Gordon JR, Tabel H: Cytokines and antibody responses during Trypanosoma congolense infections in two inbred mouse strains that differ in resistance. Parasite Immunol 1999;2:57-71.
22. Dunn AJ: The role of interleukin-1 and tumor necrosis factor alpha in the neurochemical and neuroendocrine responses to endotoxin. Brain Res Bull 1992;6:807-812.
23. Francis J, MohanKumar SM, MohanKumar PS: Correlations of norepinephrine release in the paraventricular nucleus with plasma corticosterone and leptin after systemic lipopolysaccharide: Blockade by soluble IL-1 receptor. Brain Res 2000;867:180-187.
24. Dunn AJ, Wang J: Cytokine effects on CNS biogenic amines. Neuroimmunomodulation 1995;2:319-328.
25. Wang J, Dunn AJ: The role of interleukin-6 in the activation of the hypothalamo-pituitary-adrenocortical axis and brain indoleamines by endotoxin and interleukin-1 beta. Brain Res 1999;815:337-348.
26. Gingrich JA, Hen R: The broken mouse: The role of development, plasticity and environment in the interpretation of phenotypic changes in knockout mice. Curr Opin Neurobiol 2000;10:146-152.
27. Lenczowski MJ, Schmidt ED, Van Dam AM, Gaykema RP, Tilders FJ: Individual variation in hypothalamus-pituitary-adrenal responsiveness of rats to endotoxin and interleukin-1 beta. Ann N Y Acad Sci 1998;856:139-147.
28. Schotanus K, Makara GB, Tilders FJ, Berkenbosch F: ACTH response to a low dose but not a high dose of bacterial endotoxin in rats is completely mediated by corticotropin-releasing hormone. Neuroimmunomodulation 1994;1:300-307.
29. Derijk R, Van Rooijen N, Tilders FJ, Besedovsky HO, Del Rey A, Berkenbosch F: Selective depletion of macrophages prevents pituitary-adrenal activation in response to subpyrogenic, but not to pyrogenic, doses of bacterial endotoxin in rats. Endocrinology 1991;129:330-338.
30. Hayley S, Merali Z, Anisman H: The acute and sensitization effects of tumor necrosis factor-α: Implications for immunotherapy as well as psychiatric and neurological conditions. Acta Neuropsychiatr 2002;14:322-335.
31. Dogan MD, Ataoglu H, Akarsu ES: Effects of different serotypes of Escherichia coli lipopolysaccharides on body temperature in rats. Life Sci 2000;67:2319-2329.